Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Determination of Particle Size in Lotions – V 2.0

Posted on By

Analytical Method Development: SOP for Determination of Particle Size in Lotions – V 2.0

Standard Operating Procedure for Determination of Particle Size in Lotions in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/261/2025
Supersedes SOP/AMD/261/2022
Page No. Page 1 of 12
Issue Date 21/05/2025
Effective Date 23/05/2025
Review Date 21/05/2026

1. Purpose

To establish a standardized method for the determination of particle size distribution in lotion formulations using laser diffraction or optical microscopy, ensuring uniformity, aesthetic properties, and product performance.

2.

Scope

This SOP applies to Analytical Method Development personnel engaged in characterizing the particle size of active or excipient phases in lotion-based formulations during formulation development, validation, and stability studies.

3. Responsibilities

  • Analytical Scientist: Performs sample dispersion and operates particle size analyzer or microscope.
  • QC Analyst: Assists in sample handling and record keeping.
  • QA Executive: Verifies data integrity and ensures compliance with method validation requirements.

4. Accountability

The Head of Analytical Method Development is accountable for ensuring correct method validation, equipment calibration, and scientific justification of particle size characterization techniques.

5. Procedure

5.1 Instrumentation Options

  1. Laser Diffraction Particle Size Analyzer (e.g., Malvern Mastersizer)
  2. Optical/Polarized Light Microscope (with calibrated micrometer scale)

5.2 Sample Preparation

  1. Ensure the lotion sample is homogenous.
  2. For laser diffraction: Disperse 1–2 mL of lotion in 20–50 mL of suitable dispersant (e.g., purified water or isopropanol) using a sonicator for 2 minutes.
  3. For microscopy: Place a drop of lotion or dispersion on a clean glass slide and cover with a coverslip.

5.3 Instrument Setup and Calibration

  1. Calibrate the particle size analyzer with a certified standard before use (Annexure-2).
  2. Set measurement parameters including obscuration, refractive index, and dispersant properties.

5.4 Measurement by Laser Diffraction

  1. Transfer the dispersion into the analyzer’s sample cell.
  2. Initiate measurement and acquire at least 3 scans per sample.
  3. Record d(10), d(50), and d(90) values.
  4. Clean the system thoroughly after use.

5.5 Measurement by Microscopy (Alternative)

  1. Observe the slide under 400x magnification.
  2. Measure at least 100 particles using an eyepiece micrometer.
  3. Calculate mean particle diameter and range.

5.6 Acceptance Criteria

  • d(50) value typically between 1 µm to 10 µm depending on formulation type
  • RSD for triplicate measurements ≤ 5%
  • No visible aggregation or bimodal distribution

5.7 Validation Parameters

  1. Precision: Repeatability and intermediate precision studies (RSD ≤ 5%)
  2. Accuracy: Verified using certified particle size standards
  3. Robustness: Studied by varying sonication time and dispersant type

6. Abbreviations

  • RSD: Relative Standard Deviation
  • d(50): Median Particle Diameter
  • QA: Quality Assurance
  • AMD: Analytical Method Development

7. Documents

  1. Particle Size Test Log – Annexure-1
  2. Instrument Calibration Certificate – Annexure-2
  3. Validation Report Summary – Annexure-3

8. References

  • USP <429>: Light Diffraction Measurement of Particle Size
  • ICH Q2(R1): Validation of Analytical Procedures
  • Ph. Eur. 2.9.31: Particle Size Distribution

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Rahul Patankar Meera Desai Sunita Reddy
Designation Analytical Scientist QA Reviewer Head – AMD
Department Analytical Method Development QA Analytical Method Development

11. Annexures

Annexure-1: Particle Size Test Log

Sample ID d(10) d(50) d(90) Status
LTN-261-01 1.5 µm 3.2 µm 6.4 µm Pass

Annexure-2: Instrument Calibration Certificate

Calibration Date Standard Used Expected (µm) Observed (µm) Status
15/05/2025 Polystyrene Latex 5.00 4.95 Pass

Annexure-3: Validation Report Summary

Particle size method validated for lotion formulation LTN-261. Repeatability (RSD = 2.1%), accuracy with certified standard (98.5%), and robustness across dispersant types confirmed. Method found suitable for routine product monitoring and release.

Revision History:

Revision Date Revision No. Details Reason Approved By
21/05/2025 2.0 Added microscopy method as alternate option Annual SOP Review Sunita Reddy
01/05/2022 1.0 Initial SOP Release New SOP QA Head
See also  Analytical Method Development: SOP for DSC Method for Thermal Behavior Analysis - V 2.0
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Elixir Department: SOP for Cleaning Flammable Solvent Equipment – V 2.0
Next Post: SOPs Lacking Definition of Critical vs. Non-Critical Deviations: A Hidden GMP Risk

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version